
Johns Hopkins Children's Center experts outline pedestrian, burn, allergy, anxiety, and candy guidance pediatricians can share before Halloween.

Johns Hopkins Children's Center experts outline pedestrian, burn, allergy, anxiety, and candy guidance pediatricians can share before Halloween.

Pumpkin carving accounts for 55% of Halloween ED injuries; AAOS outlines prevention tips for carving, costumes, and trick-or-treating.

NHIS data show the share of US children aged 5 to 17 years ever diagnosed with ADHD climbed from 9.9% in 2019 to 13.8% in 2025.

A proposed rule would revise iodine, manganese, and vitamin A and D levels in infant formula and reaffirm 4 other nutrient specifications.

A review of 93 studies links pediatric home-based hospice and palliative care to fewer hospital days, lower costs, and better family QOL.

With California WNV activity at a 5-year high, CHLA outlines age-based repellent and bite-prevention guidance for children.

Missed the AAP's new congenital measles guidance? This easy-to-read FAQ covers what pediatric clinicians need to know.

Self-harm risk in ADHD peaked in the 90 days before medication initiation and declined once treatment began, a 5-system analysis found.

Jon Matthew Farber, MD, shares his thoughts on using early sodium supplementation to helop with growth in premature infants.

Ellen Fremion, MD, explains how pediatricians can prepare children with medical complexity for adult care and address gaps in services and support.

In a home-based crossover study, 15 minutes of tablet video before bed did not suppress melatonin or alter sleep in toddlers aged 15-24 months.

AHA, AAP, ACOG, and SMFM issued a Female Life Stage framework that starts cardiovascular risk assessment at perimenarche, around ages 8 to 15.

In PROGRESS Cohort 2, zilurgisertib reduced total HO volume vs placebo at 24 weeks in children aged 6 to 11 with FOP, with no new HO lesions.

A four-dose 25-valent PCV series elicited responses to all 25 serotypes in infants, with serotype 3 GMCs ~15-fold higher than PCV20 after dose 4.

Registry data presented at ASN Kidney Week 2026 linked SCD-PED to higher 90-day survival vs historical controls in pediatric sepsis-associated AKI.

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

The FDA approved insulin icodec-abae for children 10+ with T2D, based on adult ONWARDS data and a single-dose pediatric pharmacokinetic study.

Johanna Chang, MD, offers guidance on vaccination, infection prophylaxis, and clinical warning signs in children receiving biologic therapies.

Adding emotion skills to family-based weight treatment didn't boost teen weight loss but cut regain and emotional eating 12 months later.

Nikta Forghani, MD, explains when irregular menstrual cycles warrant evaluation and how pediatricians can identify PCOS and relative energy deficiency.

FDA draft guidance proposes cadmium limits of 10 to 45 ppb for processed foods for children younger than 2, from purees to dry infant cereals.

Lower maternal PlGF in the third trimester was tied to child ADHD in a University of Iowa cohort, independent of preeclampsia and FGR.

A Contemporary Pediatrics Peer Exchange panel reviews RSV risk, testing, maternal vaccination, and long-acting monoclonal antibodies, and where infants still slip through the cracks.

FDA approves berotralstat 150-mg oral pellets for HAE prophylaxis in patients 12+ who cannot or prefer not to swallow capsules.

In a meta-analysis of 46 RCTs, behavioral interventions modestly improved HbA1c in youth with T1D; family-focused approaches worked best.

A GBD analysis of 204 countries estimated measles cases in children under 5 rose from 11.1 million in 2019 to 15.6 million in 2023.

Missed the AAP's new pediatric UTI guideline? This easy-to-read FAQ covers the key changes in diagnosis, treatment, imaging, and prevention.

Christina Boull, MD, explains how pediatricians can recognize dermatologic conditions in darker skin tones and address pigment changes and treatment gaps.

Tezepelumab produced histologic remission in up to 68.9% of patients aged 12+ with EoE vs 3.5% with placebo at week 24, sustained to week 52.

Black race was the strongest predictor of T2-high inflammation in 451 children with severe asthma adjusted for social and environmental factors.